Financhill
Sell
41

NHI Quote, Financials, Valuation and Earnings

Last price:
$69.91
Seasonality move :
1.97%
Day range:
$68.00 - $70.89
52-week range:
$51.59 - $86.13
Dividend yield:
5.15%
P/E ratio:
24.00x
P/S ratio:
9.26x
P/B ratio:
2.58x
Volume:
687.1K
Avg. volume:
271.5K
1-year change:
22.67%
Market cap:
$3.2B
Revenue:
$319.8M
EPS (TTM):
$2.91
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $318.1M $332.8M $298.7M $278.2M $319.8M
Revenue Growth (YoY) 7.97% 4.63% -10.25% -6.87% 14.97%
 
Cost of Revenues $5.8M $9.7M $11.6M $9.8M $11.5M
Gross Profit $312.3M $323.2M $287.1M $268.4M $308.3M
Gross Profit Margin 98.18% 97.1% 96.1% 96.48% 96.4%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $13.9M $14.6M $19.3M $25.3M $19.8M
Other Inc / (Exp) -$3.3M $13.3M -$22.4M -$22.4M $13.8M
Operating Expenses $92.3M $98.2M $101.8M $135.6M $129.5M
Operating Income $220M $224.9M $185.3M $132.8M $178.8M
 
Net Interest Expenses $56.3M $52.9M $50.8M $44.9M $58.2M
EBT. Incl. Unusual Items $160.4M $185.3M $112M $65.4M $134.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $160.4M $185.3M $112M $65.5M $134.4M
 
Minority Interest in Earnings $7K -$185K -$163K $902K $1.3M
Net Income to Common Excl Extra Items $160.5M $185.1M $111.8M $66.4M $135.7M
 
Basic EPS (Cont. Ops) $3.70 $4.14 $2.45 $1.48 $3.13
Diluted EPS (Cont. Ops) $3.67 $4.14 $2.44 $1.48 $3.13
Weighted Average Basic Share $43.4M $44.7M $45.7M $44.8M $43.4M
Weighted Average Diluted Share $43.7M $44.7M $45.7M $44.8M $43.4M
 
EBITDA $290.8M $318M $240.9M $178.7M $259.9M
EBIT $214M $234.8M $160.1M $107.9M $190M
 
Revenue (Reported) $318.1M $332.8M $298.7M $278.2M $319.8M
Operating Income (Reported) $220M $224.9M $185.3M $132.8M $178.8M
Operating Income (Adjusted) $214M $234.8M $160.1M $107.9M $190M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $84.3M $73.8M $76.3M $80.1M $82.9M
Revenue Growth (YoY) 3.21% -12.42% 3.34% 4.99% 3.54%
 
Cost of Revenues $4.2M $3.2M $2.4M $2.9M $2.8M
Gross Profit $80.1M $70.7M $73.9M $77.2M $80.2M
Gross Profit Margin 95.03% 95.69% 96.91% 96.37% 96.64%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3M $3.8M $4.8M $4.5M $5.1M
Other Inc / (Exp) -$728K -$3M $3.5M -$1M -$3.3M
Operating Expenses $23.8M $24M $31.8M $32.1M $33.6M
Operating Income $56.3M $46.6M $42.1M $45.1M $46.5M
 
Net Interest Expenses $12.9M $12.7M $11.4M $15.1M $14.9M
EBT. Incl. Unusual Items $42.7M $30.8M $34.2M $29M $28.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $42.7M $30.8M $34.2M $29M $28.2M
 
Minority Interest in Earnings -$66K -$35K $239K $313K $298K
Net Income to Common Excl Extra Items $42.6M $30.8M $34.5M $29.3M $28.5M
 
Basic EPS (Cont. Ops) $0.95 $0.67 $0.78 $0.68 $0.66
Diluted EPS (Cont. Ops) $0.95 $0.67 $0.78 $0.68 $0.65
Weighted Average Basic Share $44.7M $45.9M $44.3M $43.4M $43.5M
Weighted Average Diluted Share $44.7M $45.9M $44.4M $43.4M $44M
 
EBITDA $75.4M $63M $62.6M $60.9M $60.1M
EBIT $54.6M $42.9M $45M $43.4M $42.3M
 
Revenue (Reported) $84.3M $73.8M $76.3M $80.1M $82.9M
Operating Income (Reported) $56.3M $46.6M $42.1M $45.1M $46.5M
Operating Income (Adjusted) $54.6M $42.9M $45M $43.4M $42.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $333.7M $310.3M $277.2M $311M $328.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.8M $10M $11.7M $11M $11.1M
Gross Profit $325M $300.3M $265.5M $300.1M $317.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.7M $19M $24.1M $19.9M $21M
Other Inc / (Exp) $19M -$4.4M -$33.3M $273K -$526K
Operating Expenses $95.5M $102.4M $117M $140.5M $132.1M
Operating Income $229.4M $197.9M $148.6M $159.6M $185.7M
 
Net Interest Expenses $55M $50.8M $44.8M $55.8M $59.5M
EBT. Incl. Unusual Items $190.2M $142.6M $70.5M $104.1M $125.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $190.2M $142.6M $70.4M $104.2M $125.6M
 
Minority Interest in Earnings -$159K -$158K $571K $1.2M $1.2M
Net Income to Common Excl Extra Items $190M $142.5M $71M $105.5M $126.8M
 
Basic EPS (Cont. Ops) $4.26 $3.13 $1.57 $2.43 $2.92
Diluted EPS (Cont. Ops) $4.26 $3.13 $1.57 $2.43 $2.91
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $324.3M $273.1M $185.6M $227.5M $251.8M
EBIT $242.6M $190.6M $112.8M $157.3M $181.9M
 
Revenue (Reported) $333.7M $310.3M $277.2M $311M $328.9M
Operating Income (Reported) $229.4M $197.9M $148.6M $159.6M $185.7M
Operating Income (Adjusted) $242.6M $190.6M $112.8M $157.3M $181.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $251.6M $229M $207.5M $240.4M $249.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.2M $7.5M $7.6M $8.7M $8.3M
Gross Profit $244.4M $221.5M $200M $231.6M $241.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11M $15.4M $20.1M $14.8M $16M
Other Inc / (Exp) $19M $1.3M -$10.8M $11.9M -$2.4M
Operating Expenses $74.6M $78.8M $92.8M $97.6M $100.2M
Operating Income $169.7M $142.7M $107.2M $134M $140.9M
 
Net Interest Expenses $40.6M $38.5M $32.5M $43.3M $44.7M
EBT. Incl. Unusual Items $148.1M $105.5M $63.9M $102.7M $93.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $148.1M $105.5M $63.9M $102.7M $93.9M
 
Minority Interest in Earnings -$162K -$135K $599K $946K $892K
Net Income to Common Excl Extra Items $148M $105.3M $64.5M $103.6M $94.7M
 
Basic EPS (Cont. Ops) $3.31 $2.30 $1.43 $2.39 $2.18
Diluted EPS (Cont. Ops) $3.31 $2.30 $1.43 $2.39 $2.17
Weighted Average Basic Share $133.9M $137M $135.9M $130.2M $130.3M
Weighted Average Diluted Share $133.9M $137.1M $136M $130.2M $131M
 
EBITDA $248.4M $203.4M $148.1M $196.9M $188.7M
EBIT $186.3M $141.9M $94.6M $144M $135.9M
 
Revenue (Reported) $251.6M $229M $207.5M $240.4M $249.4M
Operating Income (Reported) $169.7M $142.7M $107.2M $134M $140.9M
Operating Income (Adjusted) $186.3M $141.9M $94.6M $144M $135.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $5.2M $43.3M $37.4M $19.3M $22.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $89.3M $98.3M $99.4M $81.9M $89.6M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $473.6M $446.8M $514.8M $383M $375.2M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $8.2M $6.2M $6.2M $6.2M $6.2M
Total Assets $3B $3.1B $2.8B $2.5B $2.5B
 
Accounts Payable $26.3M $25.2M $23.2M $25.9M $34.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $92.9M $87.6M $70.2M $112M $324.4M
 
Long-Term Debt $1.4B $1.5B $1.2B $1.1B $890.1M
Capital Leases -- -- -- -- --
Total Liabilities $1.5B $1.6B $1.3B $1.2B $1.2B
 
Common Stock $446K $452K $459K $434K $434K
Other Common Equity Adj -- -- -- -- --
Common Equity $1.5B $1.5B $1.5B $1.3B $1.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $621K $10.7M $9.9M $19.7M $20.1M
Total Equity $1.5B $1.5B $1.5B $1.3B $1.3B
 
Total Liabilities and Equity $3B $3.1B $2.8B $2.5B $2.5B
Cash and Short Terms $5.2M $43.3M $37.4M $19.3M $22.3M
Total Debt $1.4B $1.5B $1.2B $1.1B $1.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $42.2M $48.4M $28.8M $16.6M $15.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $92.4M $99.9M $82M $88.7M $92.6M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $421.9M $450.3M $350.5M $372.4M $357.1M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $29.4M $33.4M $17.4M $6.2M $6.2M
Total Assets $3.1B $2.9B $2.5B $2.5B $2.5B
 
Accounts Payable $32.1M $20.9M $23M $29.3M $32.5M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $95.7M $68.8M $67.1M $73.8M $395.4M
 
Long-Term Debt $1.5B $1.3B $1.1B $1.1B $817.3M
Capital Leases -- -- -- -- --
Total Liabilities $1.6B $1.4B $1.2B $1.2B $1.2B
 
Common Stock $447K $459K $434K $434K $436K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $11M $10.1M $20.3M $20.7M $18.5M
Total Equity $1.5B $1.5B $1.3B $1.3B $1.2B
 
Total Liabilities and Equity $3.1B $2.9B $2.5B $2.5B $2.5B
Cash and Short Terms $42.2M $48.4M $28.8M $16.6M $15.6M
Total Debt $1.5B $1.3B $1.1B $1.1B $1.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $160.4M $185.3M $112M $65.5M $134.4M
Depreciation & Amoritzation $76.8M $83.2M $80.8M $70.9M $70M
Stock-Based Compensation $3.6M $3.1M $8.4M $8.6M $4.6M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $241M $232.1M $210.9M $185.3M $184.5M
 
Capital Expenditures -- $158K $64K -- $3.7M
Cash Acquisitions -- -$875K -- -- --
Cash From Investing -$342.5M -$89.7M $185.3M $197.9M -$11.6M
 
Dividends Paid (Ex Special Dividend) -$179.7M -$194.6M -$182.9M -$161.8M -$156.2M
Special Dividend Paid
Long-Term Debt Issued $397M $305M $491.8M $225M $564M
Long-Term Debt Repaid -$204.7M -$250.7M -$752.4M -$318.4M -$576.4M
Repurchase of Common Stock -- -- -- -$152M --
Other Financing Activities -$1.1M -$6.1M -$7.4M $5.9M -$1.1M
Cash From Financing $107.3M -$111.8M -$403M -$401.3M -$169.7M
 
Beginning Cash (CF) $9.9M $15.7M $46.3M $39.5M $21.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.8M $30.7M -$6.9M -$18M $3.1M
Ending Cash (CF) $15.7M $46.3M $39.5M $21.5M $24.6M
 
Levered Free Cash Flow $241M $232M $210.8M $185.3M $180.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $42.7M $30.8M $34.2M $29M $28.2M
Depreciation & Amoritzation $20.8M $20M $17.5M $17.5M $17.8M
Stock-Based Compensation $457K $989K $1.1M $866K $670K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $59.7M $49M $43.5M $49.7M $48.6M
 
Capital Expenditures $104K -- $528K $1.1M $2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.3M $158.1M $54.9M -$19.9M -$1.6M
 
Dividends Paid (Ex Special Dividend) -$49.2M -$41.3M -$40.2M -$39.1M -$39.1M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $100M $35M $70M $52M $124M
Long-Term Debt Repaid -$125.3M -$185.1M -$60.1M -$43.1M -$124.6M
Repurchase of Common Stock $293K -- -$82M -- --
Other Financing Activities -$1.3M -$290K -$539K -$366K -$6.5M
Cash From Financing -$70.7M -$191.6M -$112.8M -$30.5M -$46.2M
 
Beginning Cash (CF) $65.4M $34.7M $46.1M $19.3M $16.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$14.3M $15.5M -$14.3M -$779K $864K
Ending Cash (CF) $51.1M $50.2M $31.7M $18.5M $17.8M
 
Levered Free Cash Flow $59.6M $49M $43M $48.6M $46.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $190.2M $142.6M $70.4M $104.2M $125.6M
Depreciation & Amoritzation $81.7M $82.5M $72.9M $70.2M $69.9M
Stock-Based Compensation $3.5M $7.7M $8.6M $4.8M $4.4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $232.7M $213.1M $192.3M $177.6M $203.4M
 
Capital Expenditures $158K $64K $528K $2.1M $4.7M
Cash Acquisitions -$875K -- -- -- --
Cash From Investing -$121M $157.1M $269.1M -$63.2M -$28.8M
 
Dividends Paid (Ex Special Dividend) -$191.4M -$190.9M -$164M -$156.2M -$156.3M
Special Dividend Paid
Long-Term Debt Issued $642M $551.8M $165M $543M $325M
Long-Term Debt Repaid -$361.7M -$802.2M -$333.3M -$513.4M -$336.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$170.5M -$7.5M $4.4M -$1M -$7.6M
Cash From Financing -$76.8M -$371.1M -$479.9M -$127.7M -$175.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $34.8M -$919K -$18.5M -$13.2M -$728K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $232.5M $213.1M $191.8M $175.6M $198.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $148.1M $105.5M $63.9M $102.7M $93.9M
Depreciation & Amoritzation $62.1M $61.5M $53.6M $52.9M $52.8M
Stock-Based Compensation $2.8M $7.4M $7.6M $3.7M $3.5M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $176.5M $157.5M $139M $131.2M $150.2M
 
Capital Expenditures $158K $64K $528K $2.6M $3.6M
Cash Acquisitions -$875K -- -- -- --
Cash From Investing -$83.4M $163.4M $247.1M -$14M -$31.1M
 
Dividends Paid (Ex Special Dividend) -$145.3M -$141.6M -$122.7M -$117.2M -$117.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $245M $491.8M $165M $483M $244M
Long-Term Debt Repaid -$157.9M -$709.4M -$290.3M -$485.3M -$245.3M
Repurchase of Common Stock -- -- -$152M -- --
Other Financing Activities -$4.3M -$5.7M $6.1M -$829K -$7.4M
Cash From Financing -$57.7M -$317M -$393.9M -$120.3M -$125.9M
 
Beginning Cash (CF) $160.9M $197.3M $125.5M $56.3M $54.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $35.4M $3.9M -$7.8M -$3M -$6.9M
Ending Cash (CF) $196.4M $201.1M $117.7M $53.3M $48M
 
Levered Free Cash Flow $176.4M $157.4M $138.5M $128.7M $146.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 9.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 13.45% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock